SEARCH

SEARCH BY CITATION

References

  • 1
    Bougie DW, Wilder PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002; 100: 20716.
  • 2
    Nurden P, Clofent-Sanchez G, Jais C, Bermejo E, Leroux L, Coste P, Nurden AT. Delayed immunological thrombocytopenia induced by abciximab. Thromb Haemost 2004; 92: 8208.
  • 3
    Abrams CS, Cines DB. Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors [Review]. Curr Haematol Rep 2004; 3: 1437.
  • 4
    Nurden AT, Poujol C, Durrieu-Jais C, Nurden P. Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects. Arterioscler Thromb Vasc Biol 1999; 19: 283540.
  • 5
    Mascelli MA, Lance ET, Damaraju L, Wagner CL, Weisman HF, Jordon RE. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade. Circulation 1998; 97: 16808.
  • 6
    Merlini PA, Rossi M, Buratti S, Brennan DM, Moliterno DJ, Topol EJ, Ardissino D. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation 2004; 109: 22036.